Nivedita Alla
Hospitalist · Morristown, NJNPI 1316071087
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 25.6% of the total. Reporting peaked in 2019 at $388 and has fallen 60.2% since, to $155 in 2025. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $14.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$468
- Novartis$464
- Pfizer$373
- Merck$216
- E.r. Squibb & Sons, L.L.C.$87
- Boston Scientific$61
- plus $162 from 9 others
What the payments were for
- Food & beverage$1,830100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 33 | $468 |
| Novartis | 33 | $464 |
| Pfizer | 24 | $373 |
| Merck | 15 | $216 |
| E.r. Squibb & Sons, L.L.C. | 6 | $87 |
| Boston Scientific | 3 | $61 |
| Amgen | 2 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $29 |
| Insmed, Inc. | 1 | $19 |
| AstraZeneca | 1 | $17 |
| AbbVie | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,830 in reported general payments places this provider in the 95th percentile of 567 hospitalist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 27 | $223 |
| Gabapentin | 11 | $183 |
| Pantoprazole Sodium | 21 | $181 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $116 |
| Prednisone | 20 | $114 |
| Amlodipine Besylate | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Morristown
- Jhonsua Jimenez AriasMorristown$15K
- Ahmed HassaninMorristown$15K
- Rebecca ZweiflerMorristown$6K
- Zainab MirzaMorristown$6K
- Brian BaksaMorristown$4K
- Vignesh RaghunathMorristown$4K
- Peter RoytmanMorristown$3K
- Christine GergesMorristown$2K
- Anamika SharmaMorristown$1K
- Shashi RajaMorristown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.